View More Recent Stories

Oct 3, 2018 04:41PM KemPharm to Host KOL Investor Event Focused on the ADHD Treatment Landscape
Sep 17, 2018 09:28AM Pre-Open Movers 09/17: (SNMX) (NBEV) (SIR) Higher; (RSLS) (PBYI) (TWTR) Lower (more...)
Sep 17, 2018 07:31AM KemPharm (KMPH) Announces Positive Topline Results from Intranasal Human Abuse Potential Trial of KP415
Sep 17, 2018 07:30AM KemPharm Announces Positive Topline Results from Intranasal Human Abuse Potential Trial of KP415 Prodrug
Sep 11, 2018 07:33AM KemPharm (KMPH) Reports Positive Topline Results from Oral Human Abuse Potential Trial of KP415 Prodrug
Sep 11, 2018 07:30AM KemPharm Announces Positive Topline Results from Oral Human Abuse Potential Trial of KP415 Prodrug
Sep 5, 2018 07:30AM KemPharm to Present at Two Healthcare Investor Conferences During September 2018
Aug 9, 2018 04:05PM KemPharm, Inc. Reports Second Quarter 2018 Results
Aug 1, 2018 07:30AM KemPharm to Present at Canaccord Genuity 38th Annual Growth Conference
Jul 31, 2018 07:30AM KemPharm, Inc. to Report Second Quarter 2018 Results
Jul 9, 2018 07:05AM KemPharm (KMPH) Says KP415.E01 Efficacy and Safety Trial in Children With ADHD Met Primary Endpoint
Jul 9, 2018 07:00AM KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD
May 10, 2018 04:05PM KemPharm Announces Positive, Topline Results from an Intravenous Human Abuse Potential Trial with KP415 Prodrug; Reports Q1 2018 Results
May 1, 2018 07:30AM KemPharm, Inc. to Report First Quarter 2018 Results
Oct 11, 2016 09:19AM Pre-Open Stock Movers 10/11: (KMPH) (SUPN) (TWLO) Higher; (RCII) (ILMN) (LITE) Lower (more...)
View More Recent Stories